Last Price
309.36
Today's Change
+6.67 (2.20%)
Day's Change
303.00 - 310.43
Trading Volume
844,854
Market Cap
8 Billion
Shares Outstanding
28 Million
Avg Volume
499,604
Avg Price (50 Days)
299.60
Avg Price (200 Days)
327.75
PE Ratio
23.63
EPS
13.09
Earnings Announcement
21-Jul-2025
Previous Close
302.69
Open
305.59
Day's Range
303.0 - 310.435
Year Range
250.05 - 459.77
Trading Volume
844,854
1 Day Change
2.20%
5 Day Change
3.33%
1 Month Change
4.59%
3 Month Change
-4.59%
6 Month Change
-8.28%
Ytd Change
-7.58%
1 Year Change
-23.43%
3 Year Change
120.53%
5 Year Change
250.23%
10 Year Change
1013.21%
Max Change
1013.21%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.